Table of Contents
ISRN Chromatography
Volume 2014, Article ID 962130, 7 pages
Research Article

Fast Stability Indicating UPLC Method for Quantitative Analysis of Dronedarone in Pharmaceutical Dosage Form: Force Degradation Study

1Department of Chemistry, Saurashtra University, Rajkot, Gujarat 360 005, India
2Arts, Commerce and Science College, Borsad, Anand, Gujarat 388540, India

Received 23 September 2013; Accepted 10 October 2013; Published 27 April 2014

Academic Editors: O. Briand and C. Deng

Copyright © 2014 Batuk Dabhi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. FDA Approves Multaq to Treat Heart Rhythm Disorder, FDA, 2009.
  2. D. Batuk, J. Yashwantsinh, P. Madhavi, J. Hetal, K. Denish, and S. Anamik, “Method development and validation of a stability indicating RP-HPLC method for the quantitative analysis of dronedarone hydrochloride in pharmaceutical tablets,” Scientia Pharmaceutica, vol. 81, pp. 115–122, 2013. View at Publisher · View at Google Scholar
  3. P. Arpan and A. Jawed, “RP-HPLC method development and validation of dronedarone HCl in its pure form and tablet dosage form,” Journal of Chemical and Pharmaceutical Research, vol. 4, pp. 2173–2179, 2012. View at Google Scholar
  4. T. Naresh, S. S. Sait, K. V. Surendranath, K. K. Ravi, and S. Kumar, “A stability indicating HPLC method for dronedarone in bulk drugs and pharmaceutical dosage forms,” The American Journal of Analytical Chemistry, vol. 3, pp. 544–551, 2012. View at Publisher · View at Google Scholar
  5. D. Batuk, J. Hetal, P. Madhavi, J. Yashwantsinh, K. Denish, and S. Anamik, “HPTLC method for estimation of dronedarone hydrochloride in both bulk drug and pharmaceutical dosage form,” International Journal of Pharmaceutical Sciences Review and Research, vol. 17, no. 1, pp. 48–51, 2012. View at Google Scholar
  6. R. W. Bolderman, J. J. R. Hermans, and J. G. Maessen, “Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection,” Journal of Chromatography B, vol. 877, no. 18-19, pp. 1727–1731, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Xie, S. Yang, D. Zhong, X. Dai, and X. Chen, “Simultaneous determination of dronedarone and its active metabolite debutyldronedarone in human plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study,” Journal of Chromatography B, vol. 879, no. 28, pp. 3071–3075, 2011. View at Publisher · View at Google Scholar · View at Scopus